Skip to main content

Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age

Abstract

Objective: To examine whether the IGF axis in pre-pubertal children born large for gestational age (LGA) differs from that of those born appropriate for gestational age (AGA). Research design and methods: The study population consisted of 98 non-obese children aged 5.5–8 yr, of whom 37 were LGA, with birth weight (BW) >90th percentile, and 61 AGA. The LGA children were subdivided into two subgroups, with BW 90th–97th percentile (no.=24) and BW >97th percentile (no.=13), respectively. Total and free IGF-I, their binding proteins 1 and 3 (IGFBP-1 and IGFBP-3), leptin, adiponectin, fasting glucose (GF) and insulin (IF) were measured, and the homeostasis model assessment for insulin resistance (HOMA-IR index) was determined. Results: IGF-I, free IGF-I and IGFBP-1 were similar in both groups. Both LGA subgroups had lower IGFBP-3 levels than the AGA group (2.34±0.61 and 2.70±0.90, respectively, vs 3.92±1.1 μg/ml, p<0.01). Adiponectin was higher in the 90th–97th percentile LGA subgroup than the AGA group (p<0.01). GF and IF were higher in the LGA group (86.5±5.6 mg/dl, p<0.01, and 5.84±2.13 μU/ml, respectively, p<0.05) than in the AGA group (82.6±7.7 mg/dl and 4.62±1.9 μU/ml, respectively), as was the HOMA-IR index (1.27±0.60 vs 0.94±0.43, p<0.01). These three parameters were also found higher in the >97th percentile LGA subgroup. Conclusion: The IGF axis was not different in pre-pubertal children born LGA or AGA, with the exception of IGFBP-3, which was lower in the LGA children. In LGA pre-pubertal children the severity of intrauterine overgrowth was associated with the insulin resistance indices.

This is a preview of subscription content, access via your institution.

References

  1. Kitzmiller JL. Macrosomia in infants of diabetic mothers: characteristics, causes, prevention. In: Jovanoic L, Peterson CM, Fuhrmann K eds. Diabetes and pregnancy: teratology, toxicology and treatment. New York: Praeger. 1986, 85–120.

    Google Scholar 

  2. Fowden AL. The role of insulin in fetal growth. In: Sakamoto S, Takeda Y eds. Advances in perinatal medicine. Amsterdam: Elsevier. 1992, 177–81.

    Google Scholar 

  3. Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum and delivery: relation to fetal weight. J Endocrinol 1991, 129: 459–64.

    PubMed  Article  CAS  Google Scholar 

  4. Shaarawy M, el-Mallah SY. Leptin and gestational weight gain: Relation of maternal and cord blood leptin to birth weight. J Soc Gynecol Investig 1999, 6: 70–3.

    PubMed  Article  CAS  Google Scholar 

  5. Wiznitzer A, Reece EA, Homko C, Furman B, Mazor M, Levy J. Insulin-like growth factors, their binding proteins and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998, 15: 23–8.

    PubMed  Article  CAS  Google Scholar 

  6. Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 194, 84: 88–95.

  7. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996, 25: 591–614.

    PubMed  Article  CAS  Google Scholar 

  8. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115: 290–6.

    Article  Google Scholar 

  9. Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 2000, 43: 283–97.

    PubMed  Article  CAS  Google Scholar 

  10. Breschi MC, Seghieri G, Bartolomei G, Gironi A, Baldi S, Ferrannini E. Relation of birth weight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia 1993, 36: 1315–21.

    PubMed  Article  CAS  Google Scholar 

  11. Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 2002, 13: 392–7.

    PubMed  Article  CAS  Google Scholar 

  12. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol 2005, 193: 1238–42.

    PubMed  Article  CAS  Google Scholar 

  13. Altman D. Sample size. In: Practical statistics for medical research. London: Chapman & Hall 1994, 456–60.

    Google Scholar 

  14. Skjaerbaek C, Vahl N, Frystyk J, et al. Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement. Eur J Endocrinol 1997, 137: 132–7.

    PubMed  Article  CAS  Google Scholar 

  15. Sun M, Schutz Y, Grezzani A, Clementi M, Gaudino R, Maffeis C. Body size and early growth in appropriate- and large-for-gestational-age infants. Acta Paediatr 2003, 92: 1127–32.

    PubMed  Article  CAS  Google Scholar 

  16. Hediger ML, Overpeck MD, Maurer KR, Kuczmarski RJ, McGlynn A, Davis WW. Growth of infants and young children born small or large for gestational age: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 1998, 152: 1225–31.

    PubMed  Article  CAS  Google Scholar 

  17. Binkin NJ, Yip R, Fleshood L, Trowbridge FL. Birth weight and childhood growth. Pediatrics 1988, 82: 828–34.

    PubMed  CAS  Google Scholar 

  18. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994, 41: 85–93.

    Article  CAS  Google Scholar 

  19. Gelander L, Blum WF, Larsson L, Rosberg S, Albertsson-Wikland K. Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study. Pediatr Res 1999, 45: 377–83.

    PubMed  Article  CAS  Google Scholar 

  20. Löfqvist C, Anderson E, Delander L, et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of Insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005, 90: 1420–7.

    PubMed  Article  CAS  Google Scholar 

  21. Patel L, Cavazzoni E, Whatmore AJ, et al. The contributions of plasma IGF-I, IGFBP-3 and leptin to growth in extremely premature infants during the first two years. Pediatr Res 2007, 61: 99–104.

    PubMed  Article  CAS  Google Scholar 

  22. Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG. Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. J Clin Endocrinol Metab 2002, 87: 4754–65.

    PubMed  Article  CAS  Google Scholar 

  23. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin dependent diabetes. J Clin Endocrinol Metab 1994, 79: 872–8.

    PubMed  CAS  Google Scholar 

  24. Saitoh H, Kamoda T, Nakahara S, Hirano T, Matsui A. Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hypeinsulinemia in prepubertal obese children. Eur J Endocrinol 1999, 140: 231–4.

    PubMed  Article  CAS  Google Scholar 

  25. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of Insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002, 359: 1740–5.

    PubMed  Article  CAS  Google Scholar 

  26. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86: 3815–9.

    PubMed  Article  CAS  Google Scholar 

  27. Sadick MD. Kinase Receptor Activation (KIRA): a rapid and accurate alternative to endpoint bioassays. Dev Biol Stand 1999, 97: 121–33.

    PubMed  CAS  Google Scholar 

  28. Chen JW, Ledet T, Orskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 2003, 284: E1149–55.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to V. I. Giapros.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Challa, A.S., Evagelidou, E.N., Giapros, V.I. et al. Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age. J Endocrinol Invest 34, 411–416 (2011). https://doi.org/10.1007/BF03346704

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346704

Key-words

  • IGF
  • adiponectin
  • leptin
  • insulin resistance
  • large for gestational age